03 April 2024
During the period from January to February 2024, the production volume of finished drugs in the Russian Federation reached an impressive 124.5 billion rubles, which marks a remarkable growth of 22.8% compared to the same period in 2023. In the first two months, pharmaceutical companies localized in Russia released 649 million packages of medicines onto the market (+6.4%). This was reported by the analytical company RNC Pharma.
It is noteworthy that the first two months of 2024 have shown a significant increase in activity among pharmaceutical manufacturers. In February, the total production volume exceeded 69.2 billion rubles, reflecting a 33% increase, while the actual volume of manufactured products reached 351.5 million packages, marking a 4.6% rise.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Health Ministry registered Russian drug for ankylosing spondylitis
06 May 2024
How gut enzymes could make universal donor blood possible
06 May 2024
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024